Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Celgene Corp (NQ: CELG)
122.58 USD  -1.06 (-0.86%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Celgene Corp
 
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes
June 13, 2007
from PR Newswire
Seven Summits Research Releases Comments on ORCL, AMD, NYX, NKE, and CELG
June 08, 2007
from PR Newswire
Celgene Corporation Will Present at the Goldman Sachs Global Healthcare Conference
June 08, 2007
from PR Newswire
Celgene Corporation Will Present at the Needham Biotechnology & Medical Technology Conference
June 07, 2007
from PR Newswire
Emerging Stock to Watch: BTEM! May 23, 2007
May 23, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts. Read More
from Marketwired News Releases
Seven Summits Research Releases Comments on RIMM, SNDK, PG, CELG, and EK
May 22, 2007
from PR Newswire
Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral Approach to Treating Inflammatory Diseases
May 22, 2007
Celgene to Advance Clinical and Regulatory Development of Oral Anti-Inflammatory Franchise Read More
from PR Newswire
SWOG Phase III Newly Diagnosed Multiple Myeloma Trial (S0232) Closed and Patients Given Choice to Switch to REVLIMID(R) Plus Dexamethasone
May 16, 2007
SWOG Action Based on Results from ECOG Phase III Study (E4A03) Read More
from PR Newswire
SWOG Phase III Newly Diagnosed Multiple Myeloma Trial (S0232) Closed and Patients Given Choice to Switch to REVLIMID(R) Plus Dexamethasone
May 15, 2007
SWOG Action Based on Results from ECOG Phase III Study (E4A03) Read More
from PR Newswire
Amphion Innovations plc (LSE: ''AMP'') Announces First Annual Science & Business Symposium ''Building Market Value from the World of Genetics''
May 14, 2007
Featured Speakers Include Amphion Innovations plc & Partner Company CEOs Read More
from Business Wire News Releases
Celgene Corporation Will Present at the Citigroup Global Healthcare Conference
May 14, 2007
from PR Newswire
Seven Summits Research Releases Comments on NVDA, TGT, CELG, FL and SNY
May 11, 2007
from PR Newswire
Celgene Corporation Will Present at the JMP Securities Research Conference
May 10, 2007
from PR Newswire
Celgene Corporation Will Present at the Acumen BioFin Rodman & Renshaw Global Healthcare Conference
May 08, 2007
from PR Newswire
Celgene Reports First Quarter Record Operating Performance and Significant Global Clinical and Regulatory Progress
May 03, 2007
2007 First Quarter Financial Results Year-Over-Year: Read More
from PR Newswire
Seven Summits Research Releases Alerts on MSFT, MCD, COF, CELG, and WMI
May 02, 2007
from PR Newswire
Celgene Corporation Will Present at the UBS Global Generic and Specialty Pharmaceuticals Conference
April 26, 2007
from PR Newswire
Celgene Corporation Will Present at the Baird Growth Stock Conference
April 25, 2007
from PR Newswire
(OTC: RCAU) to Partner With Sonic Automotive Group's eCommerce Leader for eAutoDrop Franchise Development
April 24, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit. Read More
from Marketwired News Releases
Celgene Corporation Will Present at the Morgan Stanley Global Healthcare Unplugged Conference
April 24, 2007
from PR Newswire
Celgene Corporation to Announce First Quarter Results on May 3, 2007
April 16, 2007
from PR Newswire
Zacks Analyst Blog Highlights: D. R. Horton, Lennar, Cost Plus and Celgene Corp.
April 11, 2007
from Business Wire News Releases
ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports LENALIDOMIDE Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma
April 04, 2007
from PR Newswire
(OTC: RCAU) Explores Potential Upgrade to Higher Exchange
April 03, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit Read More
from Marketwired News Releases
Oral Cancer Drug REVLIMID(R) Receives Positive Opinion for Treatment of Multiple Myeloma From European Medicines Agency
March 23, 2007
from PR Newswire
Seven Summits Research Releases Alerts on GE, INTC, NEM, CELG, and ELN
March 19, 2007
from PR Newswire
Wall Street News Alert: ORMP Is Thursday's Stock to Watch! March 15, 2007
March 15, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. Read More
from Marketwired News Releases
Celgene Corporation Will Present at the Cowen and Company 27th Annual Healthcare Conference
March 07, 2007
from PR Newswire
SmallCapStockAlert.com: VIASPACE Security Fortifies Talent Behind SHINE Expert System Development
February 28, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit. Read More
from Marketwired News Releases
(OTC: APPI) Appoints Florida Legal Counsel for the Transition Into World Health Energy
February 26, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit. Read More
from Marketwired News Releases
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here